62180 Federal Register / Vol. 69, No. 205 / Monday, October 25, 2004 / Rules and Regulations 

1 42 U.S.C. 6294. The statute also requires the 

Department of Energy (‘‘DOE’’) to develop test 

procedures that measure how much energy the 

appliances use, and to determine the representative 

average cost a consumer pays for the different types 

of energy available.

2Reports for refrigerators, refrigerator-freezers, 

and freezers are due August 1.

3The Commission’s analysis excluded models 

with energy consumption figures that do not meet 

the current DOE energy conservation standards. See

62 FR 23102 (April 28, 1997).

4See November 19, 2001 (66 FR 57867), 

November 26, 2001 (66 FR 59050), December 10, 

2001 (66 FR 63749), January 29, 2002 (67 FR 4173), 

and November 21, 2003 (68 FR 65631).

corrects that amendment number. In all 

other respects, the original document 

remains the same.

DATES: Effective October 25, 2004.

FOR FURTHER INFORMATION CONTACT:

Tomaso DiPaolo, Aerospace Engineer, 

Chicago Aircraft Certification Office, 

FAA, Small Airplane Directorate, 2300 

East Devon Avenue, Des Plaines, IL 

60018; telephone: (847) 294–7031; fax: 

(847) 294–7834.

SUPPLEMENTARY INFORMATION: A final 

rule; request for comments AD, FR Doc. 

04–22728, that applies to certain 

Hartzell Propeller Inc. (formerly Hartzell 

Propeller Products Division) Model HC–

B5MP–3( )/M10282A( )+6 five bladed 

propellers, was published in the Federal 

Register on October 14, 2004, (69 FR 

60952). The following correction is 

needed:

§ 39.13 [Corrected] 

On page 60953, in the third column, 

in the Amendatory Language, in the first 

paragraph, in the fifth line, 

‘‘Amendment 39–XXXXX’’ is corrected 

to read ‘‘Amendment 39–13822’’.

Issued in Burlington, MA, on October 18, 

2004. 

Francis A. Favara, 

Acting Manager, Engine and Propeller 

Directorate, Aircraft Certification Service.

[FR Doc. 04–23815 Filed 10–22–04; 8:45 am] 

BILLING CODE 4910–13–P

FEDERAL TRADE COMMISSION

16 CFR Part 305

Rule Concerning Disclosures 

Regarding Energy Consumption and 

Water Use of Certain Home Appliances 

and Other Products Required Under 

the Energy Policy and Conservation 

Act (‘‘Appliance Labeling Rule’’)

AGENCY: Federal Trade Commission.

ACTION: Final rule.

SUMMARY: The Federal Trade 

Commission (‘‘Commission’’) 

announces that the current ranges of 

comparability for refrigerators, 

refrigerator-freezers, and freezers will 

remain in effect until further notice.

DATES: Effective January 24, 2004.

FOR FURTHER INFORMATION CONTACT:

Hampton Newsome, Attorney, Division 

of Enforcement, Federal Trade 

Commission, Washington, DC 20580 

(202–326–2889); hnewsome@ftc.gov.

SUPPLEMENTARY INFORMATION: The 

Appliance Labeling Rule (‘‘Rule’’) was 

issued by the Commission in 1979, 44 

FR 66466 (November 19, 1979), in 

response to a directive in the Energy 

Policy and Conservation Act of 1975 

(‘‘EPCA’’).1 The Rule covers several 

categories of major household 

appliances including refrigerators, 

refrigerator-freezers, and freezers.

I. Background 

The Rule requires manufacturers of all 

covered appliances to disclose specific 

energy consumption or efficiency 

information (derived from the DOE test 

procedures) at the point of sale in the 

form of an ‘‘EnergyGuide’’ label, fact 

sheets (for some appliances), and in 

catalogs. The Rule requires 

manufacturers to include, on labels and 

fact sheets, an energy consumption or 

efficiency figure and a ‘‘range of 

comparability.’’ This range shows the 

highest and lowest energy consumption 

or efficiencies for all comparable 

appliance models so consumers can 

compare the energy consumption or 

efficiency of other models similar to the 

labeled model. The Rule also requires 

manufacturers to include, on labels for 

some products, including those that are 

the subject of this notice, a secondary 

energy usage disclosure in the form of 

an estimated annual operating cost 

based on a specified DOE national 

average cost for the fuel the appliance 

uses. 

Section 305.8(b) of the Rule requires 

manufacturers, after filing an initial 

report, to report certain information 

annually to the Commission by 

specified dates for each product type.2

These reports, which are to assist the 

Commission in preparing the ranges of 

comparability, contain the estimated 

annual energy consumption or energy 

efficiency ratings for the appliances 

derived from tests performed pursuant 

to the DOE test procedures. Because 

manufacturers regularly add new 

models to their lines, improve existing 

models, and drop others, the data base 

from which the ranges of comparability 

are calculated is constantly changing. 

To keep the required information on 

labels consistent with these changes, the 

Commission will publish new ranges if 

an analysis of the new information 

indicates that the upper or lower limits 

of the ranges have changed by more 

than 15%. Otherwise, the Commission 

will publish a statement that the prior 

ranges remain in effect for the next year.

II. 2004 Refrigerator Data 

The annual submissions of data for 

refrigerators, refrigerator-freezers, and 

freezers have been made and analyzed 

by the Commission. The ranges of 

comparability for the products have not 

changed significantly for these 

products.3 Therefore, the current ranges 

for these products (16 CFR Part 305, 

Appendices A1 through A8 and B1 

through B3) will remain in effect until 

further notice.4

List of Subjects in 16 CFR Part 305

Advertising, Energy conservation, 

Household appliances, Labeling, 

Reporting and recordkeeping 

requirements.

■ The authority citation for part 305 

continues to read as follows:

Authority: 42 U.S.C. 6294.

By direction of the Commission. 

Donald S. Clark, 

Secretary.

[FR Doc. 04–23820 Filed 10–24–04; 8:45 am] 

BILLING CODE 6750–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES

Food and Drug Administration

21 CFR Part 520

Oral Dosage Form New Animal Drugs; 

Praziquantel Tablets

AGENCY: Food and Drug Administration, 

HHS.

ACTION: Final rule.

SUMMARY: The Food and Drug 

Administration (FDA) is amending the 

animal drug regulations to reflect 

approval of a supplemental abbreviated 

new animal drug application (ANADA) 

filed by Phoenix Scientific, Inc. The 

supplemental ANADA provides for use 

of oral praziquantel tablets for the 

removal of certain tapeworm parasites 

in dogs.

DATES: This rule is effective October 25, 

2004.

FOR FURTHER INFORMATION CONTACT:

Lonnie W. Luther, Center for Veterinary 

Medicine (HFV–104), Food and Drug 

Administration, 7519 Standish Pl., 

Rockville, MD 20855, 301–827–8549, email: lonnie.luther@fda.gov.

Federal Register / Vol. 69, No. 205 / Monday, October 25, 2004 / Rules and Regulations 62181

SUPPLEMENTARY INFORMATION: Phoenix 

Scientific, Inc., 3915 South 48th St. Ter., 

St. Joseph, MO 64503, filed a 

supplement to ANADA 200–265 that 

provides for use of PRAZI–C 

(praziquantel) Tablets for the removal of 

certain tapeworm parasites in dogs. 

Phoenix Scientific, Inc.’s PRAZI–C 

Tablets are approved as a generic copy 

of Bayer HealthCare LLC’s Tape Worm 

Tabs approved under NADA 111–798. 

The supplemental ANADA is approved 

as of September 15, 2004, and the 

regulations are amended in 21 CFR 

520.1870 to reflect the approval. The 

basis of approval is discussed in the 

freedom of information summary.

In accordance with the freedom of 

information provisions of 21 CFR part 

20 and 21 CFR 514.11(e)(2)(ii), a 

summary of safety and effectiveness 

data and information submitted to 

support approval of this application 

may be seen in the Division of Dockets 

Management (HFA–305), Food and Drug 

Administration, 5630 Fishers Lane, rm. 

1061, Rockville, MD 20852, between 9 

a.m. and 4 p.m., Monday through 

Friday.

The agency has determined under 21 

CFR 25.33(a)(1) that this action is of a 

type that does not individually or 

cumulatively have a significant effect on 

the human environment. Therefore, 

neither an environmental assessment 

nor an environmental impact statement 

is required.

This rule does not meet the definition 

of ‘‘rule’’ in 5 U.S.C. 804(3)(A) because 

it is a rule of ‘‘particular applicability.’’

Therefore, it is not subject to the 

congressional review requirements in 5 

U.S.C. 801–808.

List of Subjects in 21 CFR Part 520

Animal drugs.

■ Therefore, under the Federal Food, 

Drug, and Cosmetic Act and under 

authority delegated to the Commissioner 

of Food and Drugs and redelegated to the 

Center for Veterinary Medicine, 21 CFR 

part 520 is amended as follows:

PART 520—ORAL DOSAGE FORM 

NEW ANIMAL DRUGS

■ 1. The authority citation for 21 CFR 

part 520 continues to read as follows:

Authority: 21 U.S.C. 360b.

■ 2. Section 520.1870 is amended by 

revising paragraph (b)(2) to read as 

follows:

§ 520.1870 Praziquantel tablets.

* * * * *

(b) * * *

(2) No. 059130 for use of the product 

described in paragraph (a)(1) of this 

section, as in paragraph (c)(1) of this 

section.

* * * * *

Dated: October 14, 2004.

Steven D. Vaughn,

Director, Office of New Animal Drug 

Evaluation, Center for Veterinary Medicine.

[FR Doc. 04–23761 Filed 10–22–04; 8:45 am]

BILLING CODE 4160–01–S

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES

Food and Drug Administration

21 CFR Part 524

Ophthalmic and Topical Dosage Form 

New Animal Drugs; Ivermectin Topical 

Solution

AGENCY: Food and Drug Administration, 

HHS.

ACTION: Final rule.

SUMMARY: The Food and Drug 

Administration (FDA) is amending the 

animal drug regulations to reflect 

approval of an abbreviated new animal 

drug application (ANADA) filed by 

Norbrook Laboratories, Ltd. The 

ANADA provides for topical use of 

ivermectin on cattle for treatment and 

control of various species of external 

and internal parasites.

DATES: This rule is effective October 25, 

2004.

FOR FURTHER INFORMATION CONTACT:

Lonnie W. Luther, Center for Veterinary 

Medicine (HFV–104), Food and Drug 

Administration, 7519 Standish Pl., 

Rockville, MD 20855, 301–827–8549, email: lonnie.luther@fda.gov.

SUPPLEMENTARY INFORMATION: Norbrook 

Laboratories, Ltd., Station Works, 

Newry BT35 6JP, Northern Ireland, filed 

ANADA 200–272 for NOROMECTIN 

(ivermectin) Pour On for Cattle. The 

application provides for topical use of 

0.5 percent ivermectin solution on cattle 

for the treatment and control of various 

species of gastrointestinal nematodes, 

lungworms, grubs, horn flies, lice, and 

mites. Norbrook Laboratories, Ltd.’s 

NOROMECTIN Pour-On for Cattle is 

approved as a generic copy of Merial 

Ltd.’s IVOMEC Pour-On for Cattle, 

approved under NADA 140–841. The 

application is approved as of September 

13, 2004, and the regulations are 

amended in 21 CFR 524.1193 to reflect 

the approval. The basis of approval is 

discussed in the freedom of information 

summary.

In accordance with the freedom of 

information provisions of 21 CFR part 

20 and 21 CFR 514.11(e)(2)(ii), a 

summary of safety and effectiveness 

data and information submitted to 

support approval of this application 

may be seen in the Division of Dockets 

Management (HFA–305), Food and Drug 

Administration, 5630 Fishers Lane, rm. 

1061, Rockville, MD 20852, between 9 

a.m. and 4 p.m., Monday through 

Friday.

The agency has determined under 21 

CFR 25.33(a)(1) that this action is of a 

type that does not individually or 

cumulatively have a significant effect on 

the human environment. Therefore, 

neither an environmental assessment 

nor an environmental impact statement 

is required.

This rule does not meet the definition 

of ‘‘rule’’ in 5 U.S.C. 804(3)(A) because 

it is a rule of ‘‘particular applicability.’’

Therefore, it is not subject to the 

congressional review requirements in 5 

U.S.C. 801–808.

List of Subjects in 21 CFR Part 524

Animal drugs.

■ Therefore, under the Federal Food, 

Drug, and Cosmetic Act and under 

authority delegated to the Commissioner 

of Food and Drugs and redelegated to the 

Center for Veterinary Medicine, 21 CFR 

part 524 is amended as follows:

PART 524—OPHTHALMIC AND 

TOPICAL DOSAGE FORM NEW 

ANIMAL DRUGS

■ 1. The authority citation for 21 CFR 

part 524 continues to read as follows:

Authority: 21 U.S.C. 360b.

§ 524.1193 [Amended]

■ 2. Section 524.1193 is amended in 

paragraph (b)(2) by adding in numerical 

order ‘‘055529’’.

Dated: October 8, 2004.

Steven D. Vaughn,

Director, Office of New Animal Drug 

Evaluation, Center for Veterinary Medicine.

[FR Doc. 04–23760 Filed 10–22–04; 8:45 am]

BILLING CODE 4160–01–S

DEPARTMENT OF THE TREASURY

Internal Revenue Service 

26 CFR Parts 1 and 602 

[TD 9160] 

RIN 1545–AY35 

Information Reporting Under Section 

6050P for Discharges of Indebtedness

AGENCY: Internal Revenue Service (IRS), 

Treasury.

ACTION: Final regulations.